Self‐micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization
Biopharmaceutics & Drug Disposition · 2023
DOI: 10.1002/bdd.2373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, 2023. Verfasst von Keisuke Makino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. Hauptthemen laut MEDLINE: Tacrolimus, Polyethylene Glycols. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The present study was undertaken to develop a self‐micellizing solid dispersion (SMSD) of tacrolimus (TAC) to improve the biopharmaceutical properties of TAC. An SMSD formulation of TAC (SMSD/TAC) and amorphous solid dispersion formulation of TAC (ASD/TAC) were prepared with Soluplus ® , an amphiphilic copolymer, and hydroxypropyl cellulose, respectively. Physicochemical properties were characterized in terms of morphology, crystallinity, storage stability, interaction of TAC with Soluplus ® , and micelle‐forming potency; pharmacokinetic behavior was also evaluated in rats. Tacrolimus in both formulations was in an amorphous state. After storage at 40°C/75% relativity humidity for 4 weeks, there were no significant changes in the crystallinity of TAC between nonaged and aged SMSD/TAC, whereas slight recrystallization was observed in aged ASD/TAC. The results of circular dichroism (CD) and infrared spectroscopic analyses were indicative of the potent drug–polymer interaction in SMSD/TAC, possibly leading to the prevention of recrystallization. Compared with other TAC samples, SMSD/TAC exhibited significant improvement in the dissolution behavior of TAC through the immediate formation of fine micelles. After the oral administration of TAC samples (10 mg TAC/kg) to rats, there was marked enhancement in systemic exposure to TAC with both formulations; in particular, SMSD/TAC achieved an increase in bioavailability ca. 20‐fold higher than crystalline TAC. The SMSD approach might provide an effective dosage form for TAC with enhanced physicochemical stability and oral absorption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
- Pharmaceutical Research and Technology Labs, Astellas Pharma Inc., Shizuoka, Japan.
- Department of Medicinal and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
ORCID-Profile: Kohei Yamada, Hideyuki Sato, Satomi Onoue
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Makino, K., Tsukada, R., Kambayashi, A., Yamada, K., Sato, H., & Onoue, S. (2023). Self‐micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.2373
Vancouver
Makino K, Tsukada R, Kambayashi A, Yamada K, Sato H, Onoue S. Self‐micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization. Biopharmaceutics & Drug Disposition. 2023. doi:10.1002/bdd.2373
BibTeX
@article{Makino2023,
author = {Makino, Keisuke and Tsukada, Ryota and Kambayashi, Atsushi and Yamada, Kohei and Sato, Hideyuki and Onoue, Satomi},
title = {Self‐micellizing solid dispersion of tacrolimus: Physicochemical and pharmacokinetic characterization},
journal = {Biopharmaceutics & Drug Disposition},
year = {2023},
doi = {10.1002/bdd.2373}
}
EUVIMED